Spyre Therapeutics annual operating margin
2016
2017
2018
2021
2022
2023
Spyre Therapeutics Operating Margin Growth & History (SYRE)
Spyre Therapeutics's operating margin was −27,347.97% for fiscal 2023.
View full Spyre Therapeutics company overviewSpyre Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −27,347.97% | −23707.74 pp |
| 2022 | 2022-12-31 | −3,640.23% | −3289.90 pp |
| 2021 | 2021-12-31 | −350.33% | +818.98 pp |
| 2018 | 2018-12-31 | −1,169.32% | −637.60 pp |
| 2017 | 2017-12-31 | −531.72% | −58.38 pp |
| 2016 | 2016-12-31 | −473.34% | — |
Spyre Therapeutics quarterly operating margin
Q2.17
Q3.17
Q1.18
Q2.18
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2023 | 2023-06-30 | −23,146.22% | −19558.54 pp |
| Q1 2023 | 2023-03-31 | −9,497.98% | −7703.49 pp |
| Q4 2022 | 2022-12-31 | −11,405.95% | −10844.98 pp |
| Q3 2022 | 2022-09-30 | −10,778.74% | −9328.20 pp |
| Q2 2022 | 2022-06-30 | −3,587.68% | −3538.72 pp |
| Q1 2022 | 2022-03-31 | −1,794.49% | −1387.85 pp |
| Q4 2021 | 2021-12-31 | −560.98% | −14.95 pp |
| Q3 2021 | 2021-09-30 | −1,450.54% | −816.28 pp |
| Q2 2021 | 2021-06-30 | −48.96% | +405.41 pp |
| Q2 2018 | 2018-06-30 | −406.64% | — |
| Q1 2018 | 2018-03-31 | −546.03% | — |
| Q3 2017 | 2017-09-30 | −634.26% | — |
| Q2 2017 | 2017-06-30 | −454.36% | — |
Spyre Therapeutics operating margin trends
Over the last five reported fiscal years, Spyre Therapeutics's operating margin decreased from −473.34% to −27,347.97%, a change of −26874.63 percentage points. The latest reported quarter, Q2 2023, shows −23,146.22%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Spyre Therapeutics filings at SEC.gov ↗